Literature DB >> 18218047

A xenograft model of infant leukaemia reveals a complex MLL translocation.

Michelle J Henderson, Seoyeon Choi, Alex H Beesley, David L Baker, Dale Wright, Rachael A Papa, Ashleigh Murch, Lynda J Campbell, Richard B Lock, Murray D Norris, Michelle Haber, Ursula R Kees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18218047     DOI： 10.1111/j.1365-2141.2007.06966.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemia.

Authors:  Jennifer Richmond; Hernan Carol; Kathryn Evans; Laura High; Agnes Mendomo; Alissa Robbins; Claus Meyer; Nicola C Venn; Rolf Marschalek; Michelle Henderson; Rosemary Sutton; Raushan T Kurmasheva; Ursula R Kees; Peter J Houghton; Malcolm A Smith; Richard B Lock
Journal:  Clin Cancer Res       Date:  2015-01-08       Impact factor: 12.531

2.  Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.

Authors:  Alex H Beesley; Janelle L Rampellini; Misty-Lee Palmer; Jasmin Y S Heng; Amy L Samuels; Martin J Firth; Jette Ford; Ursula R Kees
Journal:  Mol Cancer       Date:  2010-10-28       Impact factor: 27.401

3.  A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.

Authors:  Andrei V Krivtsov; Kathryn Evans; Jayant Y Gadrey; Benjamin K Eschle; Charlie Hatton; Hannah J Uckelmann; Kenneth N Ross; Florian Perner; Sarah N Olsen; Tara Pritchard; Lisa McDermott; Connor D Jones; Duohui Jing; Ali Braytee; Diego Chacon; Eric Earley; Brian M McKeever; David Claremon; Andrew J Gifford; Heather J Lee; Beverly A Teicher; John E Pimanda; Dominik Beck; Jennifer A Perry; Malcolm A Smith; Gerard M McGeehan; Richard B Lock; Scott A Armstrong
Journal:  Cancer Cell       Date:  2019-12-09       Impact factor: 31.743

4.  Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia.

Authors:  Laurence C Cheung; Rebecca de Kraa; Joyce Oommen; Grace-Alyssa Chua; Sajla Singh; Anastasia M Hughes; Emanuela Ferrari; Jette Ford; Sung K Chiu; Ronald W Stam; Ursula R Kees; Sébastien Malinge; Rishi S Kotecha
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

5.  Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.

Authors:  Erica Ballabio; Thomas A Milne
Journal:  Cancers (Basel)       Date:  2012-09-10       Impact factor: 6.639

6.  Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin.

Authors:  M N Cruickshank; J Ford; L C Cheung; J Heng; S Singh; J Wells; T W Failes; G M Arndt; N Smithers; R K Prinjha; D Anderson; K W Carter; A M Gout; T Lassmann; J O'Reilly; C H Cole; R S Kotecha; U R Kees
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.